EP3929190 - COMPOUNDS AND COMPOSITIONS FOR MODULATING EGFR MUTANT KINASE ACTIVITIES [Right-click to bookmark this link] | Status | Grant of patent is intended Status updated on 06.08.2024 Database last updated on 19.10.2024 | |
Former | Examination is in progress Status updated on 22.06.2023 | ||
Former | Request for examination was made Status updated on 01.07.2022 | ||
Former | The application has been published Status updated on 26.11.2021 | Most recent event Tooltip | 13.09.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Yuhan Corporation 74 Noryangjin-ro Dongjak-gu Seoul 06927 / KR | [2021/52] | Inventor(s) | 01 /
SUH, Byung-Chul Lexington, 02420 / US | 02 /
SALGAONKAR, Paresh Devidas Medford, 02155 / US | 03 /
LEE, Jaekyoo North Andover, 01845 / US | 04 /
KOH, Jong Sung 14414 Gyeonggi-do / KR | 05 /
SONG, Ho-Juhn Andover, 01810 / US | 06 /
LEE, In Yong Belmont, 02478 / US | 07 /
LEE, Jaesang Belmont, 02478 / US | 08 /
JUNG, Dong Sik 31089 Chungcheongnam-do / KR | 09 /
KIM, Jung-Ho 13565 Gyeonggi-do / KR | 10 /
KIM, Se-Won 13517 Gyeonggi-do / KR | [2021/52] | Representative(s) | Dehns 10 Old Bailey London EC4M 7NG / GB | [N/P] |
Former [2021/52] | Dehns St. Bride's House 10 Salisbury Square London EC4Y 8JD / GB | Application number, filing date | 21171619.6 | 13.10.2015 | [2021/52] | Priority number, date | US201462063394P | 13.10.2014 Original published format: US 201462063394 P | [2021/52] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3929190 | Date: | 29.12.2021 | Language: | EN | [2021/52] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 08.10.2021 | Classification | IPC: | C07D403/04, A61K31/506, A61K31/4155, A61K31/167, A61P35/00 | [2021/52] | CPC: |
C07D403/04 (EP,CN,US);
C07D403/14 (EP,CN,KR,US);
A61K31/506 (KR,US);
A61P11/00 (EP);
A61P25/00 (EP);
A61P31/00 (EP);
A61P35/00 (EP,KR);
A61P37/00 (EP,KR);
A61P37/02 (EP);
A61P43/00 (EP);
A61P9/00 (EP);
C07D401/14 (CN);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/31] |
Former [2021/52] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Title | German: | VERBINDUNGEN UND ZUSAMMENSETZUNGEN ZUR MODULATION DER KINASEAKTIVITÄTEN VON EGFR-MUTANTEN | [2021/52] | English: | COMPOUNDS AND COMPOSITIONS FOR MODULATING EGFR MUTANT KINASE ACTIVITIES | [2021/52] | French: | COMPOSÉS ET COMPOSITIONS DE MODULATION DES ACTIVITÉS DE KINASE MUTANT EGFR | [2021/52] | Examination procedure | 28.06.2022 | Examination requested [2022/31] | 28.06.2022 | Date on which the examining division has become responsible | 25.07.2022 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time | 04.10.2022 | Amendment by applicant (claims and/or description) | 21.06.2023 | Despatch of a communication from the examining division (Time limit: M06) | 27.12.2023 | Reply to a communication from the examining division | 07.08.2024 | Communication of intention to grant the patent | Parent application(s) Tooltip | EP15850314.4 / EP3207035 | EP19196713.2 / EP3604294 | Divisional application(s) | EP24166947.2 / EP4421069 | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report | 04.10.2022 | Request for further processing filed | 04.10.2022 | Full payment received (date of receipt of payment) Request granted | 17.10.2022 | Decision despatched | Fees paid | Renewal fee | 11.08.2021 | Renewal fee patent year 03 | 11.08.2021 | Renewal fee patent year 04 | 11.08.2021 | Renewal fee patent year 05 | 11.08.2021 | Renewal fee patent year 06 | 29.09.2021 | Renewal fee patent year 07 | 15.09.2022 | Renewal fee patent year 08 | 13.09.2023 | Renewal fee patent year 09 | 12.09.2024 | Renewal fee patent year 10 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]US2010029610 (SINGH JUSWINDER [US], et al); | [A]WO2011060295 (GENOSCO [US], et al); | [A]WO2013014448 (ASTRAZENECA AB [SE], et al); | [IP]WO2015025197 (JUBILANT BIOSYS LTD [IN]); | [XP]CN104788427 (PHARMARESOURCES SHANGHAI CO LTD); | [E]WO2015188777 (SHANGHAI FOCHON PHARMACEUTICAL CO LTD [CN]); | by applicant | WO2006102642 | WO2007023105 | WO2007117465 | WO2011060295 | WO2013109882 | US8626132 |